"We have a lot of skeptics out there who believe there is no innovation in China. Well there is. We have access to a huge base of innovation."
Mireille Gillings, president and CEO, HUYA Bioscience International, during the China Track at the J.P. Morgan Healthcare Conference

"It's the first and only time in the world that anybody's had the courage to say that heparin's a crap drug – something we've been saying for about 10 years."
Clive Meanwell, chairman and CEO of the Medicines Co., on last year's downgrading of heparin from a Class I to a Class II recommendation by the European Society of Cardiology

"There's a need for therapies that can be given for prolonged periods to keep those patients comfortable and decrease the need for transfusions."
Steven E. Benner, chief medical officer, Cell Therapeutics Inc., on initiating a Phase III trial for its JAK2 inhibitor, pacritinib, in myelofibrosis